Elevation of surfactant protein A in plasma and sputum in cigarette smokers

Mazur W., Toljamo T., Ohlmeier S., Vuopala K., Nieminen P., Kobayashi H., Kinnula V.L.

Source: Eur Respir J 2011; 38: 277-284
Journal Issue: August
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mazur W., Toljamo T., Ohlmeier S., Vuopala K., Nieminen P., Kobayashi H., Kinnula V.L.. Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur Respir J 2011; 38: 277-284

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005


Total desmosines in plasma and urine correlate with lung function
Source: Eur Respir J 2012; 39: 839-845
Year: 2012



Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Source: Eur Respir J 2005; 26: 835-845
Year: 2005



Effects of N-acetylcystein on oxidant-antioxidant activity in smokers with chronic obstructive pulmonary disease
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005


8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD
Source: Eur Respir J 2007; 29: 51-55
Year: 2007



Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007



Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Source: Eur Respir J 2004; 24: 964-970
Year: 2004



Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005


Extracellular matrix composition in COPD
Source: Eur Respir J 2012; 40: 1362-1373
Year: 2012



Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers
Source: Eur Respir J 2013; 41: 1058-1067
Year: 2013



Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation
Source: Eur Respir J 2005; 25: 447-454
Year: 2005



Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD
Source: Eur Respir J 2009; 34: 95-102
Year: 2009



Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with  chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




Sampling the lung fluids: peripheral biomarkers
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007


Micro-RNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010

Decrease of vascular endothelial growth factor in macrophages from long-term smokers
Source: Eur Respir J 2005; 25: 626-633
Year: 2005



Evidence for harm reduction in diseased smokers
Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited
Year: 2007


A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010


Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012